Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial.

De Marco G, Hensor EMA, Helliwell PS, Sultan S, Dubash SR, Michelena X, Coates LC, Emery P, Tan AL, McGonagle D, Marzo-Ortega H

Open source

DOI: 10.1016/s2665-9913(25)00156-0
Published: 2025 Nov
Container: The Lancet. Rheumatology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-25-00156-0,
  title = {Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial.},
  author = {De Marco G and Hensor EMA and Helliwell PS and Sultan S and Dubash SR and Michelena X and Coates LC and Emery P and Tan AL and McGonagle D and Marzo-Ortega H},
  year = {2025},
  journal = {The Lancet. Rheumatology},
  doi = {10.1016/s2665-9913(25)00156-0},
  url = {https://doi.org/10.1016/s2665-9913(25)00156-0}
}

RIS

TY  - JOUR
TI  - Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial.
AU  - De Marco G
AU  - Hensor EMA
AU  - Helliwell PS
AU  - Sultan S
AU  - Dubash SR
AU  - Michelena X
AU  - Coates LC
AU  - Emery P
AU  - Tan AL
AU  - McGonagle D
AU  - Marzo-Ortega H
PY  - 2025
JO  - The Lancet. Rheumatology
DO  - 10.1016/s2665-9913(25)00156-0
UR  - https://doi.org/10.1016/s2665-9913(25)00156-0
ER  -

APA

G, D. M., EMA, H., PS, H., S, S., SR, D., X, M., LC, C., P, E., AL, T., D, M., & H, M. (2025). Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(25)00156-0

Source records

pubmed · retrieved 2026-09-26T15:20:23.690Z
europe-pmc · retrieved 2026-09-26T15:20:23.672Z